<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9496530</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">36140422</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">9496530</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3390/biomedicines10092321</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">biomedicines-10-02321</article-id></all-ids><extracted-table><table-id>biomedicines-10-02321-t001</table-id><table-label>Table 1</table-label><table-caption>Demographics of participants.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="biomedicines-10-02321-t001"><object-id pub-id-type="pii">biomedicines-10-02321-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographics of participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HiAmy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">LowAmy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HC</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Number of participants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27<break/>(16 AD, 11 AmyMCI)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31<break/>(13 VD, 18 NamyMCI)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"/></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Age (mean ± SD)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74 ± 7.17<break/>(55–87)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77 ± 6.23<break/>(66–88)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72 ± 6.34<break/>(60–85)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.245</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sex (M:F)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16:11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11:20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16:9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.412</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HK-MoCA score</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 ± 5.91<break/>(3–24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 ± 4.23<break/>(7–27)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.063</td></tr></tbody></table><table-wrap-foot><fn><p>Between-group differences in age, sex and clinical performances were tested using the Kruskal–Wallis test according to the level of measurement. Statistical significance was set statistical significance was set at <italic toggle="yes">p</italic> &lt; 0.05. <italic toggle="yes">p</italic>-Value quoted are the asymptomatic significance of the Kruskal–Wallis test. HiAmy: High amyloid group; LowAmy: Low amyloid group; HC: Healthy controlsHiAmy: High amyloid group; LowAmy: Low amyloid group; HC: Healthy controls.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>biomedicines-10-02321-t001_Table 1Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographics of participants.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"/><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">HiAmy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">LowAmy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">HC</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin">p-Value</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin">Number of participants</td><td align="center" valign="middle" style="border-bottom:solid thin">27(16 AD, 11 AmyMCI)</td><td align="center" valign="middle" style="border-bottom:solid thin">31(13 VD, 18 NamyMCI)</td><td align="center" valign="middle" style="border-bottom:solid thin">25</td><td align="center" valign="middle" style="border-bottom:solid thin"/></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Age (mean ± SD)</td><td align="center" valign="middle" style="border-bottom:solid thin">74 ± 7.17(55–87)</td><td align="center" valign="middle" style="border-bottom:solid thin">77 ± 6.23(66–88)</td><td align="center" valign="middle" style="border-bottom:solid thin">72 ± 6.34(60–85)</td><td align="center" valign="middle" style="border-bottom:solid thin">0.245</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">Sex (M:F)</td><td align="center" valign="middle" style="border-bottom:solid thin">16:11</td><td align="center" valign="middle" style="border-bottom:solid thin">11:20</td><td align="center" valign="middle" style="border-bottom:solid thin">16:9</td><td align="center" valign="middle" style="border-bottom:solid thin">0.412</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin">HK-MoCA score</td><td align="center" valign="middle" style="border-bottom:solid thin">19 ± 5.91(3–24)</td><td align="center" valign="middle" style="border-bottom:solid thin">20 ± 4.23(7–27)</td><td align="center" valign="middle" style="border-bottom:solid thin">N/A</td><td align="center" valign="middle" style="border-bottom:solid thin">0.063</td></tr></tbody></table></div>Between-group differences in age, sex and clinical performances were tested using the Kruskal–Wallis test according to the level of measurement. Statistical significance was set statistical significance was set at p &lt; 0.05. p-Value quoted are the asymptomatic significance of the Kruskal–Wallis test. HiAmy: High amyloid group; LowAmy: Low amyloid group; HC: Healthy controlsHiAmy: High amyloid group; LowAmy: Low amyloid group; HC: Healthy controls.</transformed-table></extracted-table></extracted-tables-set>